Chronic dosing with mirtazapine does not produce sedation in rats

OBJECTIVE: Sedation/somnolence are major side effects of pharmacotherapies for depression, and negatively affect long-term treatment compliance in depressed patients. Use of mirtazapine (MIR), an atypical antidepressant approved for the treatment of moderate to severe depression with comorbid anxiet...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar-Juárez, Alberto, Barbosa-Méndez, Susana, Merino-Reyes, Paola, Matus-Ortega, Maura, Hernández-Calderón, Jorge A., Antón, Benito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111384/
https://www.ncbi.nlm.nih.gov/pubmed/28355345
http://dx.doi.org/10.1590/1516-4446-2016-2058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111384/
https://www.ncbi.nlm.nih.gov/pubmed/28355345
http://dx.doi.org/10.1590/1516-4446-2016-2058

Ejemplares similares